Policy / Regulatory

NMPA Releases 109th RLD Catalog for Chemical Generics – 30 New Product Specifications Added, 24 Supplemented
GQCE testing

NMPA Releases 109th RLD Catalog for Chemical Generics – 30 New Product Specifications Added, 24 Supplemented

China's National Medical Products Administration (NMPA) released the 109th Catalog of Reference Listed Drugs for Chemical Generic Drugs, adding 30 new product specifications and supplementing information for 24 product specifications…

US Treasury Drafts China Pharma Investment Rules Likely to Preserve Licensing Deals – A Carve‑Out From Broader National‑Security Tightening

US Treasury Drafts China Pharma Investment Rules Likely to Preserve Licensing Deals – A Carve‑Out From Broader National‑Security Tightening

China's NHC Issues Landmark Rare‑Disease Notice – Mandating Province‑Wide Clinics and Quality Control Networks by End‑2026

China’s NHC Issues Landmark Rare‑Disease Notice – Mandating Province‑Wide Clinics and Quality Control Networks by End‑2026

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Contact US
National Health Commission Launches Integrated Medical and Elder Care Demonstration Projects
NHC (NHFPC)

National Health Commission Launches Integrated Medical and Elder Care Demonstration Projects

CDE Seeks Feedback on 96th Batch of Chemical Generic Drug Reference Standards
CDEGQCE testing

CDE Seeks Feedback on 96th Batch of Chemical Generic Drug Reference Standards

Hebei Implements Separate Payment for 57 Negotiated Drugs Starting August 1, 2025
BMI

Hebei Implements Separate Payment for 57 Negotiated Drugs Starting August 1, 2025

Konruns' KC1036 Proposed for CDE's SPARK Program to Accelerate Pediatric Ewing’s Sarcoma Treatment Development
CancerKonruns Pharmaceutical

Konruns’ KC1036 Proposed for CDE’s SPARK Program to Accelerate Pediatric Ewing’s Sarcoma Treatment Development

Show More